• Abeona Therapeutics Announces CEO Transition firstwordpharma
    November 27, 2018
    Abeona Therapeutics Inc. (Nasdaq: ABEO), a leading clinical-stage biopharmaceutical company focused on developing novel cell and gene therapies for life-threatening rare genetic diseases
PharmaSources Customer Service